Barclays maintains overweight on Coca-Cola EP, target at $85

EditorLina Guerrero
Published 04/09/2024, 21:26
Barclays maintains overweight on Coca-Cola EP, target at $85
CCEP
-

On Wednesday, Barclays reaffirmed its confidence in Coca-Cola European Partners (NASDAQ:CCEP), maintaining an Overweight rating and a price target of $85.00. The endorsement comes despite a challenging second quarter for the company, which was adversely affected by weather conditions.

Barclays acknowledges the impact of the weather on CCEP's Q2 performance but emphasizes the company's strong underlying demand and competitive positioning.

The investment firm remains steadfast in its medium-term outlook for CCEP, projecting stability for the current year and the future, although it recognizes that the potential for sales growth in FY24 may not be as high as previously anticipated. Despite this slight adjustment in expectations, Barclays expresses a positive view of the company's prospects, citing the "relative visibility and quality of execution" that CCEP consistently demonstrates.

Barclays' analysis suggests that while short-term challenges have surfaced, they do not significantly detract from the company's overall trajectory. The firm's commentary indicates a belief that CCEP is well-positioned to navigate market fluctuations and maintain its competitive edge.

In summary, Barclays underscores the resilience of Coca-Cola (NYSE:KO) European Partners' business model and operational effectiveness. The investment firm's rating and price target reflect a vote of confidence in CCEP's ability to deliver sustained performance and shareholder value in the midst of a dynamic market environment.

In other recent news, Coca-Cola Europacific Partners has maintained a 'Buy' rating from Citi, with the firm citing potential growth in the Asia-Pacific South region. Despite anticipating a subdued second quarter for European operations due to unfavorable weather conditions, Citi expects a slight increase in first-half volumes, mainly driven by better performance in the Philippines.

The firm also suggests that Coca-Cola Europacific Partners' management is unlikely to alter their full-year 2024 guidance at this point, with consensus estimates for EBIT growth in 2024 already exceeding the company's own guidance.

Citi also commented on the possibility of a London listing for the company, which is not anticipated before the fourth quarter of this year. Ahead of Coca-Cola Europacific Partners' earnings results, the firm has expressed caution due to a combination of factors, including potential increased promotional activity in Great Britain and the stock trading at high price-to-earnings ratios relative to historical averages.

Despite this, Citi notes that the risk/reward balance for Coca-Cola Europacific Partners' stock is tilting towards the downside, given disappointing second-quarter results from other companies in the beverage sector.

InvestingPro Insights

Barclays' optimistic stance on Coca-Cola European Partners (NASDAQ:CCEP) is mirrored by several key metrics and InvestingPro Tips that highlight the company's financial health and market position. The company boasts a robust market capitalization of $37.36 billion, underlining its significant presence in the industry. With a Price/Earnings (P/E) ratio of 20.94, CCEP trades at a valuation that is reflective of its earnings potential, and it has demonstrated a solid track record of profitability over the last twelve months.

InvestingPro Tips suggest that CCEP has a history of rewarding shareholders, having increased its dividend for three consecutive years. Despite analysts anticipating a sales decline in the current year, the company's stock is known for low price volatility, providing a degree of stability for investors. Moreover, CCEP is trading near its 52-week high, indicating strong investor confidence and market performance.

For readers interested in a deeper dive into Coca-Cola European Partners' financials and strategic positioning, InvestingPro offers additional tips and insights. As of now, there are six more tips available on InvestingPro that can provide further guidance on CCEP's performance and outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.